Results 171 to 180 of about 108,209 (253)

Estimating Organism Abundance Using Within‐Sample Haplotype Frequencies of eDNA Data

open access: yesMolecular Ecology Resources, Volume 26, Issue 2, February 2026.
ABSTRACT Environmental DNA (eDNA) provides powerful insights into species presence and community composition but remains limited in its capacity to infer species abundance or population structure. Here, we show that the deviation between within‐sample haplotype frequencies and the overall population‐level haplotype frequencies can be used to estimate ...
Pedro F. P. Brandão‐Dias   +4 more
wiley   +1 more source

Exploration of Multiple Non‐Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 3, Page 396-404, February 2026.
This study investigated multiple non‐invasive tests (NIT) in a phase 2b study of patients with MASH and fibrosis treated with semaglutide. Findings revealed that semaglutide significantly improved NIT scores versus placebo from as early as 28 weeks. The results support the use of NITs to assess a treatment response to semaglutide.
Louise Maymann Nitze   +8 more
wiley   +1 more source

Examining the Association Between Perceived Quality of Care and Experienced Coercion Among Patients in Acute Mental Health Units in Spain: A National Cross‐Sectional Study

open access: yesJournal of Clinical Nursing, Volume 35, Issue 2, Page 766-774, February 2026.
ABSTRACT Aim To examine the association between perceived quality of care and the level of coercion experienced by individuals hospitalised in acute mental health units. Design National cross‐sectional study. Methods Data were collected from 255 patients admitted to 12 acute mental health units across Spain.
Khadija El‐Abidi   +20 more
wiley   +1 more source

Progression to Decompensation of Severe Fibrosis Compared to Cirrhosis in MASLD: A Systematic Review and Meta‐Analysis

open access: yesLiver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background & Aims Metabolic associated steatotic liver disease (MASLD) is increasing in prevalence worldwide. Clinical practice is focused on identifying those with cirrhosis and monitoring for complications such as varices and hepatocellular carcinoma (HCC).
Rachael Barrett   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy